PLoS Pathogens (Jan 2012)

Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells.

  • Anna Martirosyan,
  • Camino Pérez-Gutierrez,
  • Romain Banchereau,
  • Hélène Dutartre,
  • Patrick Lecine,
  • Melissa Dullaers,
  • Marielle Mello,
  • Suzana Pinto Salcedo,
  • Alexandre Muller,
  • Lee Leserman,
  • Yves Levy,
  • Gerard Zurawski,
  • Sandy Zurawski,
  • Edgardo Moreno,
  • Ignacio Moriyón,
  • Eynav Klechevsky,
  • Jacques Banchereau,
  • Sangkon Oh,
  • Jean-Pierre Gorvel

DOI
https://doi.org/10.1371/journal.ppat.1002983
Journal volume & issue
Vol. 8, no. 11
p. e1002983

Abstract

Read online

Bacterial cyclic glucans are glucose polymers that concentrate within the periplasm of alpha-proteobacteria. These molecules are necessary to maintain the homeostasis of the cell envelope by contributing to the osmolarity of Gram negative bacteria. Here, we demonstrate that Brucella β 1,2 cyclic glucans are potent activators of human and mouse dendritic cells. Dendritic cells activation by Brucella β 1,2 cyclic glucans requires TLR4, MyD88 and TRIF, but not CD14. The Brucella cyclic glucans showed neither toxicity nor immunogenicity compared to LPS and triggered antigen-specific CD8(+) T cell responses in vivo. These cyclic glucans also enhanced antigen-specific CD4(+) and CD8(+) T cell responses including cross-presentation by different human DC subsets. Brucella β 1,2 cyclic glucans increased the memory CD4(+) T cell responses of blood mononuclear cells exposed to recombinant fusion proteins composed of anti-CD40 antibody and antigens from both hepatitis C virus and Mycobacterium tuberculosis. Thus cyclic glucans represent a new class of adjuvants, which might contribute to the development of effective antimicrobial therapies.